Features | Partner Sites | Information | LinkXpress
Sign In
Bio-Rad Diabetes Division
RANDOX LABORATORIES
FOCUS DIAGNOSTICS, INC.

Gout Detected from a Simple Blood Sample

By Labmedica International staff writers
Posted on 31 Oct 2013
An in vitro diagnostic test, which detects active Gout disease from samples of whole blood, has been launched in Europe.

The CE marked GoutiFind test takes a new approach to Gout diagnosis. Based on a key scientific discovery of how our immune system reacts to uric acid crystal deposition in joints, the GoutiFind test measures the cellular immune response to the deposits. No special clinical setting is required for the GoutiFind test. A fresh blood sample drawn in a physician’s office or clinical laboratory is all that is required for the GoutiFind test.

The GoutiFind test is offered throughout the EU as a diagnostic service by Boulder Diagnostics (Mellrichstadt, Germany) clinical diagnostic service laboratory. The GoutiFind test detects active Gout disease without employing the unreliable determination of the uric acid level. It therefore provides a noninvasive reliable diagnosis of Gout disease.

The GoutiFind test can replace the invasive joint puncture method for Gout detection and thus make reliable Gout diagnosis available to a much broader range of medical institutions and physician practices. The test is based on measuring the cellular immune response to a specific challenge with a Gout stimulus.

"The GoutiFind test simplifies and makes Gout diagnosis more broadly available," commented Dr. Wolfgang Pieken, CEO of Boulder Diagnostics Inc., and added, "the GoutiFind test is the second product from our technology platform that queries the trained immunity for active disease."

"At our clinical laboratory in Mellrichstadt, Germany, we now accept whole blood samples for Gout detection by the GoutiFind method," stated Dr. Anton Waldherr, laboratory physician of Boulder Diagnostics Europe GmbH.

Related Links:

Boulder Diagnostics



77 ELEKTRONIKA
DiagCor Bioscience
DRG International
comments powered by Disqus
Sekisui Diagnostics

Channels

Clinical Chemistry

view channel
Image: The gel zymography separation of matrix metalloproteinases (MMPs) on a 7.5% polyacrylamide gel (Photo courtesy of the Italian National Research Council).

Quantitative Gel Zymography Reappraised for Matrix Metalloproteinases

A reappraisal of quantitative gel zymography technique for matrix metalloproteinases (MMPs) in human plasma has been used for comparison with commercially available enzyme-linked immunosorbent assay (ELISA).... Read more

Industry News

view channel

French-German Cooperation to Improve Personalized Cancer Care

A leading French oncology center will be collaborating with a German manufacturer of molecular diagnostic tests to develop new approaches to personalized cancer care. The Gustave Roussy Cancer Campus (Paris, France), a medical center with 2,600 health professionals dedicated to cancer diagnosis and treatment that devotes... Read more
 

Events

06 Nov 2014 - 08 Nov 2014
12 Nov 2014 - 15 Nov 2014
Copyright © 2000-2014 Globetech Media. All rights reserved.